[ad_1]
Blockbuster obesity drug Wegovy has been approved in China, opening the door for maker Novo Nordisk to begin selling it in the world’s second-largest economy, where the appetite for similar treatments is surging.
[ad_1]
Blockbuster obesity drug Wegovy has been approved in China, opening the door for maker Novo Nordisk to begin selling it in the world’s second-largest economy, where the appetite for similar treatments is surging.
Starboard Value said it issued its letter to highlight shareholders’ dissatisfaction with Autodesk’s response to…
The electric-vehicle company issued two other recalls of the futuristic truck earlier this year.
Jun 16, 2024, 12:11:05 PM ISTNippon India Mutual Fund manages assets under management totaling Rs.…
Sign in to your account